Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells (Q38945636)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells (English)

1 reference

Europe PubMed Central

7 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

Nicolas Chomont

1

object named as

Nicolas Chomont

1 reference

Europe PubMed Central

7 September 2017

author name string

Hakim Hocini

2

1 reference

Europe PubMed Central

7 September 2017

Jean-Chrysostome Gody

3

1 reference

Europe PubMed Central

7 September 2017

Hicham Bouhlal

4

1 reference

Europe PubMed Central

7 September 2017

Pierre Becquart

5

1 reference

Europe PubMed Central

7 September 2017

Corinne Krief-Bouillet

6

1 reference

Europe PubMed Central

7 September 2017

Michel Kazatchkine

7

1 reference

Europe PubMed Central

7 September 2017

Laurent Bélec

8

1 reference

Europe PubMed Central

7 September 2017

language of work or name

0 references

publication date

24 October 2007

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

370

1 reference

Europe PubMed Central

7 September 2017

2

1 reference

Europe PubMed Central

7 September 2017

246-254

1 reference

Europe PubMed Central

7 September 2017

HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Compartmentalization of the IgG immune response to HIV-1 in breast milk

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Neutralization of primary human immunodeficiency virus type 1 isolates: a study of parameters implicated in neutralization in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

In vitro models of mucosal HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Transmission of human immunodeficiency virus type 1 through breast-feeding: how can it be prevented?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

based on heuristic

inferred from DOI database lookup

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

based on heuristic

inferred from DOI database lookup

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2007.09.006

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38945636&oldid=1797742434"